发明名称 Use of carbacycline derivs. - for treating atopic disorders, e.g. dermatitis, allergic rhinitis and bronchial asthma
摘要 Carbacylin derivs. (I) can be used in the prepn. of an agent for the treatment of atopic disorders. USE/ADVANTAGE - (I) can now be used to treat atopic dermatitis, allergic rhinitis and bronchiral asthma. (I) inhibit TNF synthesis at the stage of TNF-messenger-RNA. (I) are used in preference to monoclonal antibodies (targetted against TNF) in that they are effective against TNF already secreted and can also act prophylactically and in contrast to monoclonal antibodies can be used topically. Also, the TNF-TNF-immune complex formed is not degraded. Suitable doses for topical use are 20-40 micro g/g/ointment/100 cm3 affected skin; the max tolerated daily dose is 80-160 mg. Nasal sprays are used in doses of 0.1-1 ng/kg/min.
申请公布号 DE4139733(A1) 申请公布日期 1993.06.03
申请号 DE19914139733 申请日期 1991.11.28
申请人 SCHERING AG BERLIN UND BERGKAMEN, 1000 BERLIN, DE 发明人 BLITSTEIN-WILLINGER, EVELINE, DR., 1000 BERLIN, DE
分类号 A61K31/557 主分类号 A61K31/557
代理机构 代理人
主权项
地址